Link to Livestream: 
http://healthcare.partners.org/streaming/Live/PHS/2020_BehavioralHealthSymposium.html

Description

Lessons from Disasters: Potential Behavior Health - Consequences of the Pandemic

• What mental health consequences we expect to see as a result of COVID in the medium- and long-term
• How do we decide when someone needs formal treatment or referral (including how to think about this in the time of virtual assessments)?
• Very quick overview of treatments that can be used 

Learning Objectives

Upon completing this session participants will be able to:

1. Describe the medium- and long-term mental health consequences and coping mechanisms expected as a result of COVID-19;
2. Differentiate when patients need formal treatment vs. referral (including in the context of virtual assessments);
3. Identify the types of treatment that can be used to support patients’ needs.

Resources

Marques_COVID-19 Resources

https://www.massgeneral.org/psychiatry/guide-to-mental-health-resources/

Target Audience 

This activity is intended for Primary Care Teams managing behavioral health (care managers/behavioral health support specialists, social workers, PCPs, psychiatric consultants).

Accreditation

Partners HealthCare System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Partners HealthCare System designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing

Course Director

Trina E. Chang, MD, MPH
Associate Medical Director for Behavioral Health Integration,
Quality and Patient Experience,
Mass General Brigham

 

Speakers

Jerry Rosenbaum, MD

Psychiatrist-in-Chief emeritus, Massachusetts General Hospital
Director Center for Anxiety and Traumatic Stress Disorders

Dr. Rosenbaum is recognized as one of the world's foremost authorities on mood and anxiety disorders, with a special emphasis on pharmacotherapy of those conditions. His research contributions include extensive participation in the design and conduct of clinical trials of new therapies, the design and implementation of trials to develop innovative treatments for major depression, treatment resistant depression, and panic disorder, studies of psychopathology including comorbidity and subtypes, and studies of longitudinal course and outcomes of those disorders.

Dr. Rosenbaum has authored more than 300 original articles and reviews and has published 12 books. He currently serves on 12 editorial boards of professional journals or newsletters. A particular research interest has been ongoing longitudinal studies of children at risk for anxiety disorders and depression, which has sought to understand risk and protective factors for later psychopathology, including early temperamental features, genetic variations and brain imaging differences.

Dr. Rosenbaum's clinical and consulting practice specializes in treatment resistant mood and anxiety disorders, and he consults extensively to colleagues on management of these conditions.

Dr. Rosenbaum received his undergraduate degree from Yale College and his medical degree from Yale School of Medicine. He completed his residency and fellowship in Psychiatry at Massachusetts General Hospital, Harvard Medical School.

Gregory Fricchione, MD

Associate Chief of Psychiatry
Director, Division of Psychiatry and Medicine, Massachusetts General Hospital
Director, Benson-Henry Institute for Mind Body Medicine

Gregory Fricchione, MD has been on faculty at Harvard Medical School (HMS) since 1993. Since July 2002 he has been Associate Chief of Psychiatry at Massachusetts General Hospital (MGH). Fricchione received his M.D. from New York University School of Medicine in 1978. He is board certified in psychiatry and has added qualifications in psychosomatic medicine and geriatric psychiatry. He has taught in the medical schools at New York University, the State University of New York at Stony Brook, the University of Auckland in New Zealand and at Emory University as well as at Harvard Medical School where he is Professor of Psychiatry.

Dr. Fricchione is Director of the Division of Psychiatry and Medicine at MGH and of the MGH Psychosmatic Medicine Fellowship Program and of the Spaulding Rehabilitation Hospital Behavioral Mental Health Service and supervises a large staff of attending and trainee psychiatrists taking care of the psychiatric problems of medically and surgically ill patients. He is also Director of the Benson-Henry Institute for Mind Body Medicine at MGH where clinical, animal and neuroimaging research into the effects of stress and resiliency take place.

David C. Henderson, MD

Chair, Psychiatry, Boston University School of Medicine
Assistant Dean, Diversity & Multicultural Affairs, Boston University School of Medicine
Boston Medical Center and BU School of Medicine

David C. Henderson, MD, currently serves as Psychiatrist-in-Chief, Division of Psychiatry, at Boston Medical Center and Professor and Chair, Department of Psychiatry, at Boston University School of Medicine. Dr. Henderson previously served as Director of The Chester M. Pierce, MD Division of Global Psychiatry at Massachusetts General Hospital (MGH), Director of the MGH Schizophrenia Clinical and Research Program, and Medical Director of the Harvard Program in Refugee Trauma. Dr. Henderson serves as Co-Director of the NIMH T32 MGH-BUSM Global Mental Health Clinical Research Fellowship. He has worked internationally for the past 21 years in resource-limited settings, and areas impacted by mass violence, disasters and complex emergencies. Dr. Henderson has conducted research and training programs in Bosnia, Cambodia, East Timor, Ethiopia, Haiti, Liberia, New Orleans, New York City, Rwanda and Peru, South Africa, and Somaliland among other places. His work has consisted of field studies, needs assessments, mental health policy development and strategic planning, quantitative and qualitative surveys, mental health capacity building programs for specialized and primary health professionals, and skill-transfer program evaluation. In the United States, he has conducted more than 30 randomized clinical trials in severely mentally ill populations. Dr. Henderson has also directed a schizophrenia research training fellowship, and mentored trainees and junior faculty who have progressed to K awards and secured other independent funding. He actively mentors 10 psychiatry residents and 4 postdoctoral fellows on data-driven international research projects